| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10011086 | HBV | ENSG00000069431.14 | protein_coding | ABCC9 | No | No | 10060 | O60706 |
| TVIS10019878 | HBV | ENSG00000069431.14 | protein_coding | ABCC9 | No | No | 10060 | O60706 |
| TVIS30032267 | HIV | ENSG00000069431.14 | protein_coding | ABCC9 | No | No | 10060 | O60706 |
| TVIS30032268 | HIV | ENSG00000069431.14 | protein_coding | ABCC9 | No | No | 10060 | O60706 |
| TVIS20050784 | HPV | ENSG00000069431.14 | protein_coding | ABCC9 | No | No | 10060 | O60706 |
| TVIS20050485 | HPV | ENSG00000069431.14 | protein_coding | ABCC9 | No | No | 10060 | O60706 |
| TVIS20050615 | HPV | ENSG00000069431.14 | protein_coding | ABCC9 | No | No | 10060 | O60706 |
| TVIS44009671 | HTLV-1 | ENSG00000069431.14 | protein_coding | ABCC9 | No | No | 10060 | O60706 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | ABCC9 |
|---|---|
| DrugBank ID | DB00171 |
| Drug Name | ATP |
| Target ID | BE0000469 |
| UniProt ID | O60706 |
| Regulation Type | |
| PubMed IDs | 16845255; 16829188; 16897043 |
| Citations | Zhao JL, Yang YJ, You SJ, Jing ZC, Wu YJ, Cheng JL, Gao RL: Pretreatment with fosinopril or valsartan reduces myocardial no-reflow after acute myocardial infarction and reperfusion. Coron Artery Dis. 2006 Aug;17(5):463-9.@@Yang YJ, Zhao JL, You SJ, Wu YJ, Jing ZC, Gao RL, Chen ZJ: Post-infarction treatment with simvastatin reduces myocardial no-reflow by opening of the KATP channel. Eur J Heart Fail. 2007 Jan;9(1):30-6. Epub 2006 Jul 7.@@Bryan J, Munoz A, Zhang X, Dufer M, Drews G, Krippeit-Drews P, Aguilar-Bryan L: ABCC8 and ABCC9: ABC transporters that regulate K+ channels. Pflugers Arch. 2007 Feb;453(5):703-18. Epub 2006 Aug 8. |
| Groups | Investigational; Nutraceutical |
| Direct Classification | Purine ribonucleoside triphosphates |
| SMILES | NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O |
| Pathways | Glycerolipid Metabolism; Fatty Acid Metabolism; Pamidronate Action Pathway; Simvastatin Action Pathway; Citric Acid Cycle; Glutamate Metabolism; Argininosuccinic Aciduria; Gluconeogenesis; Betaine Metabolism; Butyrate Metabolism; 2-Methyl-3-hydroxybutryl-CoA Dehydrogenase Deficiency; Rosuvastatin Action Pathway; Propanoate Metabolism; Pentose Phosphate Pathway; Pyruvate Metabolism; Inositol Metabolism; Zoledronate Action Pathway; Glycine and Serine Metabolism; Selenoamino Acid Metabolism; Thiamine Metabolism; Pyrimidine Metabolism; Carbamoyl Phosphate Synthetase Deficiency; Ammonia Recycling; Histidine Metabolism; Pravastatin Action Pathway; Arginine and Proline Metabolism; Starch and Sucrose Metabolism; Purine Metabolism; Fluvastatin Action Pathway; Galactose Metabolism |
| PharmGKB | PA164743471 |
| ChEMBL | CHEMBL14249 |
